Literature DB >> 7416738

Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.

R Vanhoof, B Gordts, R Dierickx, H Coignau, J P Butzler.   

Abstract

The bacteriostatic and bactericidal activities of 24 antimicrobial agents were tested with the Dynatech MIC 2000 system against 86 strains of Campylobacter fetus subsp. jejuni from human sources. The penicillins (penicillin G, ampicillin, amoxycillin, carbenicillin) had poor activity. Ampicillin and amoxycillin were equally active. Cefotaxime revealed a rather good activity. Erythromycin, gentamicin, tobramycin, amikacin, and furazolidone were the most active compounds. Two strains (2.3%) were resistant to erythromycin. One strain (1.2%) was completely resistant to tobramycin. The tetracyclines (tetracyline, doxycycline, minocycline) were generally effective, but 8% of the strains were totally resistant to them. Minocycline was the most active. Chloramphenicol, thiamphenicol, and clindamycin had good activity. The bacteriostatic and bactericidal distributions for colistin, nalidixic acid, and metronidazole were broad.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7416738      PMCID: PMC283949          DOI: 10.1128/AAC.18.1.118

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  [Campylobacter and enteritis].

Authors:  W P Severin
Journal:  Ned Tijdschr Geneeskd       Date:  1978-04-15

3.  Acute enteritis due to related vibrio: first positive stool cultures.

Authors:  P Dekeyser; M Gossuin-Detrain; J P Butzler; J Sternon
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

4.  Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics.

Authors:  J P Butzler; P Dekeyser; T Lafontaine
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

5.  Erythromycin-resistant Campylobacters.

Authors:  M Walder; A Forsgren
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

6.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

7.  In-vitro activity of new cephalosporin (HR 756) and cefazolin.

Authors:  R Vanhoff; J P Butzler; E Yourassowsky
Journal:  Lancet       Date:  1978-07-22       Impact factor: 79.321

8.  Campylobacter enteritis in Central Africa.

Authors:  P De Mol; E Bosmans
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

9.  Campylobacter enteritis in Brussels.

Authors:  S Lauwers; M De Boeck; J P Butzler
Journal:  Lancet       Date:  1978-03-18       Impact factor: 79.321

10.  Campylobacter enteritis in children.

Authors:  M A Karmali; P C Fleming
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

View more
  33 in total

1.  Cloning and expression of a tetracycline resistance determinant from Campylobacter jejuni in Escherichia coli.

Authors:  F C Tenover; D J LeBlanc; P Elvrum
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  Disk sensitivity testing for Campylobacter jejuni.

Authors:  R Vanhoof; R Dierickx; H Coignau; J M Hubrechts; L Kaufman; J P Butzler
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

3.  Relapsing septicemia caused by Campylobacter fetus subsp. fetus.

Authors:  J Righter; W A Wells; G D Hart; D J McNeely
Journal:  Can Med Assoc J       Date:  1983-03-15       Impact factor: 8.262

4.  Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.

Authors:  J Michel; M Rogol; D Dickman
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

5.  Susceptibility testing of Campylobacter fetus subsp. jejuni, using broth microdilution panels.

Authors:  G E Buck; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.

Authors:  M A Karmali; S De Grandis; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

7.  Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.

Authors:  H Hof; V Sticht-Groh
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

8.  A modified broth-disk antibiotic susceptibility test for Campylobacter jejuni.

Authors:  S L Welkos
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

9.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

10.  In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.

Authors:  B M Flores; C L Fennell; K K Holmes; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.